Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

OBJECTIVES: To develop European League Against Rheumatism (EULAR) recommendations for the management of small and medium vessel vasculitis. METHODS: An expert group (consisting of 10 rheumatologists, 3 nephrologists, 2 immunologists, 2 internists representing 8 European countries and the USA, a clinical epidemiologist and a representative from a drug regulatory agency) identified 10 topics for a systematic literature search using a modified Delphi technique. In accordance with standardised EULAR operating procedures, recommendations were derived for the management of small and medium vessel vasculitis. In the absence of evidence, recommendations were formulated on the basis of a consensus opinion. RESULTS: In all, 15 recommendations were made for the management of small and medium vessel vasculitis. The strength of recommendations was restricted by low quality of evidence and by EULAR standardised operating procedures. CONCLUSIONS: On the basis of evidence and expert consensus, recommendations have been made for the evaluation, investigation, treatment and monitoring of patients with small and medium vessel vasculitis for use in everyday clinical practice.

Original publication

DOI

10.1136/ard.2008.088096

Type

Journal article

Journal

Annals of the rheumatic diseases

Publication Date

03/2009

Volume

68

Pages

310 - 317

Addresses

University of Oxford, Oxford, UK.

Keywords

European Vasculitis Study Group, Humans, Vasculitis, Cyclophosphamide, Methotrexate, Immunosuppressive Agents, Biological Markers, Antibodies, Antineutrophil Cytoplasmic, Glucocorticoids, Plasma Exchange, Drug Therapy, Combination, Evidence-Based Medicine